Free Trial

Cardlytics (CDLX) Expected to Announce Earnings on Wednesday

Cardlytics logo with Business Services background

Cardlytics (NASDAQ:CDLX - Get Free Report) is anticipated to announce its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect Cardlytics to post earnings of ($0.27) per share and revenue of $58.07 million for the quarter.

Cardlytics Stock Performance

Cardlytics stock traded up $0.31 during midday trading on Monday, hitting $2.15. The company's stock had a trading volume of 1,254,140 shares, compared to its average volume of 1,020,400. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The company has a market cap of $111.91 million, a price-to-earnings ratio of -0.35 and a beta of 1.30. Cardlytics has a 1-year low of $1.22 and a 1-year high of $15.89. The company has a 50-day moving average price of $1.86 and a two-hundred day moving average price of $3.03.

Insider Transactions at Cardlytics

In other news, CFO Alexis Desieno sold 24,778 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. This trade represents a 10.07 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 71,938 shares of company stock valued at $244,017. Corporate insiders own 4.40% of the company's stock.

Analyst Ratings Changes

CDLX has been the subject of a number of analyst reports. Lake Street Capital dropped their price target on shares of Cardlytics from $5.00 to $3.00 and set a "hold" rating for the company in a research report on Thursday, March 13th. Evercore ISI cut their target price on Cardlytics from $4.00 to $3.00 and set an "in-line" rating for the company in a research report on Thursday, March 13th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cardlytics in a research report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $6.42.

Check Out Our Latest Stock Report on CDLX

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Stories

Earnings History for Cardlytics (NASDAQ:CDLX)

Should You Invest $1,000 in Cardlytics Right Now?

Before you consider Cardlytics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardlytics wasn't on the list.

While Cardlytics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines